ASP3291
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ASP3291, covering 2012-07-24 to 2016-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis [Phase 2]